Upload
hiroshi
View
212
Download
0
Embed Size (px)
Citation preview
CLIN. AND EXPER. HYPER.-THEORY AND PRACTICE, A12(5), 865-876 (1990)
GENETICS OF HYPERTENSION: WHAT WE KNOW AND DON’T KNOW
ROGER R. WILLIAMS, STEVEN C. HUNT, SANDRA J. HASSTEDT, PAUL N. HOPKINS, LILY L WU, MOMAS D.
BERRY, BARRY M. STULTS, GARY K. BARLOW, AND HlROSHl KUlDA
CARDIOVASCULAR GENmCS RESEARCH WNIC, UNMRSrrY OF UTAH MEDICAL SCHOOC. SALT LAKE CITY,
UTAH, USA
SUMMARY
Human arterial hypertenslon Is likely a multlfactorlal trait resulting from multlple
measurable monogenes, blended polygenes, shared family environment, and Indlvldual
environment. Familial aggregation of hypertension and familial correlation of blood
pressure appears to be more due to genes than to shared family environment. Total genetic
heritability of 80% with some recessive major gene effects have been found for several traits
assoclated with hypertenslon Including urinary kallikreln excretlon, intraerythrocytlc
sodium, and sodium-lithium countertransport. Other interesting factors regarding
hypertenslon genetics Include: non-modulatlon of the renln anglotensln system,
intralymphocytlc sodium, ionized calcium, and several genetic markers such as haptoglobin,
HIA, and MNS blood type. Probably the most cllnlcally useful lnformatlon regardlng the
genetics of hypertension Is evolving In several studies reporting a strong associatlon of
hypertenslon with dyslipkiemla, diabetes, and obesity. Key words: hypertenslongenetlcs-
epldemlology-pathophyslology-blochemls~ry-llplds-famlly history-coronary heart dlsease.
INTRODUCTION
Hypertenslon Is one of the most common chronic diseases and one of the most common reasons for
asymptomatlc persons taking prescription medicatlon. It has consistently been one of the
most prominent risk factors for myocardial lnfarctlon and stroke, the most common causes of
death in many countrles. The large number and expense of studies used to determine belter
865
C o p y r a t 0 1990 by Marcel Dekker, inc.
Clin
Exp
Hyp
erte
ns D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y M
cMas
ter
Uni
vers
ity o
n 11
/28/
14Fo
r pe
rson
al u
se o
nly.
866 WILLIAMS ET AL.
methods for diagnosing, treating and preventing arterlal hypertenslon reflect the hlgh
prlority of understandlng this disorder.
Whle numerous studies have found individual pleces in the puzzle of the pathophyufology of
hypertension, a clear picture of exactly how they all M together Is not yet available. From
all indications, genetic factors must play a very Important rde in this overall picture.
While the studles are numerous, and the methods are cornpllcated, e few basic observations
illustrate some consistent answers to important questions regarding the genetics of
hypertension. They also helped to point to other important questions for which answers are
not yet available.
FAMILIAL CORRELATION
Population-based studles of different types of family members have consistently shown that
Mood pressure correlates very well in related famlly members and poorly among spouses and
adopted children with their parents who share the same environment but do not share the same
genes (1-5). Some of the specHIc obsewations are shown in TaMe 1.
Familial correlations can be due to shared family environment or assortatlve mating as well
as genes. As shown In Table 2, several Important variables shown to be assoclated with
Table 1. Blood Pressure Correlatlons In Familleg
Pearson Cor relation
Famiiv Members &&) SBP DBP
Spouse Pairs (1433) 0.08 0.06
Adoptees - Parents (379) 0.03 0.09
Offspring - Parents (831) 0.18 0.16
Sibling Pairs (2618) 0.18 0.14
DZ Twins (264) 0.25 0.27
Mi! Twins (248) 0.55 0.58
Combined data from 5 studles: Framingham (l), Tecumseh (2), Evans County (3).
Canadian Adoptlon (4). and NHLBI twins (5).
Clin
Exp
Hyp
erte
ns D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y M
cMas
ter
Uni
vers
ity o
n 11
/28/
14Fo
r pe
rson
al u
se o
nly.
GENETICS OF HYPERTENSION
Table 2. Familv Correlations Fo r Non Ge netic Variab igg
Variables intraclgss Correlation Coeffi&nts
Tested MZ114Q ,-) Bro1219) &L@U)
Education 0.57 a 0.55 a 0.40 a 0.47 a
Alcohol 0.70 a 0.24 c 0.40 a 0.50 a
Smoking 0.68 a 0.11 0.16 C 0.31 a
Salt Use 0.38 b 0.20 0.28 a 0.23 a
Exercise 0.41 a 0.12 0.16 C 0.18 a
a = P < 0.001
Results after adjusting for age (and sex within spouse pair), from Utah twins
and pedigrees (6). Number of persons indicated in parentheses.
b = P < 0.01 c = P < 0.05
hypertension show excellent correlations in twins, brothers, and spouses. A higher degree
of correlation among monozygous (MZ) twins when compared to dizygous (DZ) twins is
mathematically interpreted as evldence for genetic herltabiilty in many studles. Following
this reasoning In TaMe 2, one would reach the conclusion that alcohd intake, current
smoking status, and frequency of vigorous aerobic exercise are all highly genetically
determined traits since they show significantly higher correlations in MZ twins than in DZ
twins. It is clear that for some environmental variables MZ twlns are more similar than DZ
twins leading to an overestimation of genetic heritability in most reported twin studies.
Shared environment often reflects habits established In childhood. This likely explains the
observation in Table 2 of significant familial correlations for frequence of salt use among
adult relatives not living in the same household. Current salt use preferences among spouses
could reflect either current shared environment or assortatbe mating for dietary
preferences.
HERITABILITY ESTIMATES FOR BLOOD PRESSURE
Using mathematical models and formulas, statisticians try to quantitate what proportion of
the total variatlon of selected variables can be explained by a Mended combination of ail
genes affecting that trait (pdygenes), and what additional proportion of the variation
coulU bb explained by shared environmental factors. This statistical estimation of
Clin
Exp
Hyp
erte
ns D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y M
cMas
ter
Uni
vers
ity o
n 11
/28/
14Fo
r pe
rson
al u
se o
nly.
868 WILLIAMS ET AL.
3: Polvae nlc and Fnviro-b I iiitv Fstlma teg
Shared (c') Variables
Tested m J 3 d U M r rnironment
2
Metabdic: Chdesterol 61% a 42% a 8%
Trigiycerkles 81% a 37% a 6%
HDL-Chd 74% a 45% a 15%
W/HT2 54% b 24% a 0%
Sitting 60% C 22% a 3%
Standing 63% 21% b 3%
Math 44% 23% a 8%
Bicycle 49% 38% a 0%
Hand Grip 50% 17% b 0%
a = P < 0.001
Results after adjusting for age and sex for all variables as well as grip
strength and workload respecthraly for hand gdp and bicycle Mood pressures.
From Utah twins and pedigrees (6).
b = P < 0.01 c = P < 0.05
variability Is called pdygenlc heritability (h*) or envlronmental heritability (cs. Table
3 presents heritability estimates from 340 Utah twins and 2,500 persons belonging to 98 Utah
pedigrees screened at the University of Utah, Cardiovascular Genetics Research Clinic.
it Is interesting to note that herltabillty estimates are consistently higher from the
analysis of twins than from pedlgrees. This could be due to failure of the mathemtlcal twln
model to account for MZ twins having more shared gene-gene interactions and greater
environmental similarity (see in Table 2). However, results from both twlns and pedigrees
consistently support signmcant polygenlc determination for all sitting diastolic Mood
pressures and several metabolic variables related to coronary risk and hypertension. The
estimates of varlance attributable to shared family environment are 80 small that a very
large sample size wodd be required to obtain statistical signmcance. From these and other
similar studies, It seems consistently established that genes rather than shared famlly
Clin
Exp
Hyp
erte
ns D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y M
cMas
ter
Uni
vers
ity o
n 11
/28/
14Fo
r pe
rson
al u
se o
nly.
GENETICS OF HYPERTENSION 869
environment are responsible for most of the familial aggregation of Mood pressure and
associated metabolic factors.
COMPLEX SEGREGATION ANALYSIS IN PEDIGREES
When family correlation studies suggest genetic determination for variables, a l og ld next
step is to test for genetic transmission, and attempt to determine the mode of transmission
(recessive, dominant, additive, poiygenlc, or mixtures of polygenlc and monogenic
transmission). Thls can currently be accomplished with sophisticated statlstlcal formulas
tested using maximum likelihood methods embedded in computer programs. While the
mathematics is complicated, the concept is quite straight forward. The computer simply looks
at the measured values of a particular trait for each person and asks simple questions such
as: Do all the values seem to fail into a single continuous distribution (supporting
poiygenic traits) or Into two or more discreet distributions (supporting recessive dominant
or additive major gene traits)? Do the values of the children tend to fall halfway between
the parents (supporting polygenic), or do they tend to fall Into one of two discreet
distributions closer to one of the two parents (supports major gene)? Do children tend to be
"affected" only when one parent is affected (dominant), or does it almost always occur when
only two parents are affected (recessive)? What percentage of offspring are 'affected' when
no parents are affected. when one parent is affected or when both parents are affected?
Mathematical models can be made even more complicated to include factors that may affect the
likelihood of an inherited trait being 'penetrant" or expressed. For example, the model
could assume 20% of gene carriers will express it under age 20 but 50% will express it over age
40. The model can also assume that among individuals with a particular allele of a monogenic
trait, variation within those subjects can be attributed to pdygenlc effects. Thls full
mathematical model of genetic transmission In pedigrees Is often referred to as the 'mked
model'. Carrying out these type of calculations for large numbers of obselvations in
pedigrees would be prohlbitive without the beneflt of electronic computers. Even with their
help, a considerable amount of work Is required for many months to obtain Informative and
reliable results. Table 4 shows the results obtained from pedigree analysis of biochemical
traits associated with human hypertension. All of them show very high total heritability
estimates, even higher than those seen for well-known genetically influenced traits such as
plasma cholesterol level (total heritability 42%). It is also interesting to note that all
of the variables shown in Table 4 have both polygenlc and recessive monogenic components.
Clin
Exp
Hyp
erte
ns D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y M
cMas
ter
Uni
vers
ity o
n 11
/28/
14Fo
r pe
rson
al u
se o
nly.
WILLIAMS ET AL.
Table 4. Heritab illtv of Bbche mtcal fra its Assoclata
Human Arterlal HvDertens Ion
Mode of Herltabllltv fh2)
Biochemical Traitg Transmlssion J&jQr+&&=m
Urlnary Kallikrein Excretion Recessive 51% 27% 78%
intraerythrocytlc Sodium Recessive 29% 55% 84%
Sodium-Lithium Countertransport Recessive 34% 46% 80%
Lithium Potassium Cotransport Recessive 14% 33% 47%
Results from several studies of multlgeneratlonal Utah pedigrees (7,8,9).
None of the traits llsted In Table 4 can be consldered as direct causal factors leading to
hypertension. They are associated with hypertension through studles showing that
slgnfflcantly different levels are observed between persons with hypertension versus these
without hypertenslon and/or between normotensive persons with and without a positive family
history of hypertenslon.
Moat of these biochemical traits are likely to be quantitative risk factors for hypertenslon
llke Mood cholesterol level Is for coronary dlsease. Whlle on the average persons with
dlsease have hlgh rlsk values and persons without the dlsease have lower risk values. hlgh
rlsk values for some traits are seen in some persons without disease, and low risk values are
seen In some persons with disease. Also llke coronary risk factors, no slngle trait likely
predlcts hypertenslon in any given lndivldual. A battery of several quantitative traits such
as those llsted In Table 4 may help predlct future hypertension just as a battery of risk
factora are now used to help predict coronary disease.
OTHER INTERESTING FACTORS
Many Interesting factors have been examined In studies of persons with and without a family
history of hypertension or In sibshlps or other famly groups where hypertension Is found.
Only a few of them are llsted In Table 5 (10-16) with longer lists presented in other reviews
(17-19). Slnce sodlum intake remains one of the most interesting environmental variables
thought to be involved In the pathophysldogy of hypertension, several of these factors are
Clin
Exp
Hyp
erte
ns D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y M
cMas
ter
Uni
vers
ity o
n 11
/28/
14Fo
r pe
rson
al u
se o
nly.
GENETICS OF HYPERTENSION a n
Table 5. Other lnterestina Fac tors Ralardlno HvDertenslon Genetlcg
Factor
Haptoglobln Genotype
HIA Qenotype
MNS Genotype
lonked Calcium
Nonmodulatlon
Renin-Anglotensln
WBC Sodlum
Dysllpldemlc HBP
Diabetes
Obeslty
lnterestino Observa tions
BP Response To Acute Sodium Loadlng
Some HBP Association & Linkage Studies
Some HBP Assoclatlon Studies
Family History of Hypertension (FHx HBP)
Bimodal, Familial, Positive FHx HBP
Be Physiology, DNA Markers Available
FHx HBP and Bicycle BP Reacttvity
FHx HBP, Coronary Risk, Insulin
Heritable Disease with HBP Common
Carries a lot of Weight In Most HBP Studies
~
Multiple studies (10-16) discussed In prior revlews (17-19).
InValVed In sodium and electrolyte metaboilsm. Different alleles of the haptoglobin
genotype were significantly associated with different Mood pressure responses to acute
sodlurn loading (10). Commonly studied genetic markers such as HLA tissue type and MNS blood
type have been shown in some studies to be associated or genetically linked to presence of
hypertension (11). Some traits such as ionized calcium and blunted response to angiotensln
I I infuslon ("non-modulation") show signlflcant dlfferences between persons wlth and without
a positive family history of hypertension (12-13). Some studies have used innovative blood
pressures and biochemical tests together. In one such study, high lntralymphocytic sodium
concentratton was associated wlth a positive family history of hypertension and even more
dramatically associated with a subset of indtviduats who had exaggerated increases In
dlastollc blood pressure in response to bicycle exercise (14).
The fleld of molecular biology Is rapidly providing tods for even more sophisticated genetic
studies. For speclflc hormones such as renln, angiotensln, and kallikreln, DNA markers are
being developed for structural genes allowing the possibility of genetic linkage studies
testing for abnormalities of these genes being associated wlth risk of hypertension. The
challenge Is flnding the right subset of patients and using the right marker. Many experts
Clin
Exp
Hyp
erte
ns D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y M
cMas
ter
Uni
vers
ity o
n 11
/28/
14Fo
r pe
rson
al u
se o
nly.
872 WILLIAMS ET AL.
advise uslng the 'candidate gene approach" in which a specific marker is selected based on
some medical or physioioglcai evidence of abnormality in the subjects for which malor gene
effects are suggested. For example, persons with very high LDL cholesterd levels with
domlnant inheritance are thought to have familial hypercholesterdemia and make Meal
candidates for DNA marker studles of the LDL receptor. A "candldate gene approach' for
hypertension could Include testing the sodlum-hydrogen transporter gene In pedigrees with
evidence from segregation analysls for a recessive gene determining sodium-lithium
countertransport. Another would be testing the structural gene for kalllkreln versus
urlrmy kailikreln excretion levels in pedlgrees showlng major gene segregation of this
trait.
HYPERTENSION: A METABOLIC DISEASE?
Llpid abnormalities, diabetes. and obesity are commonly associated with hypertension. Recent
data suggest the hypothesls that some hypertenslon results from inherited metabolic
abnormalities reinforced by appropriate environmental exposures. A network of physldoglc
lnteractlons that could help explain much of the Inter-relatedness between llpld
abnormalities, diabetes, hypertenslon, and W O M ~ ~ heart disease Is illustrated in Figure
1. Developing unpublished data in Utah suggests that between 2540% of famllles with early
coronary disease occurring before age 55 have evidence of familial aggregatlon of metabolic
abnormalities shown in Figure 1. While the exact cause and genetic relationships of these
metabolic abnormalitles remains to be determined, practical benefit can be gained from even
the general notion of the assoclatlons shown In Figure 1. Because some hypertension is
associated with ltpid abnormalities, it is useful to measure cholesterd, triglycerlde and
HDL cholesterol levels In persons with hypertension, especially if they have a family history
of hypertension or early coronary disease. Much of the risk of coronary disease In persons
with diabetes may also be associated with these metabolic abnormalities, emphasizing the
need to search for hypertenslon and lipid abnormalities among persons with diabetes.
Recognlzlng the potential adverse effects of some antihypertensbe medications on blood
lipids and glucose tolerance can help clinicians choose the appropriate medications that
will be most helpful and least harmful to persons who may also have the metabolic
abnormalities shown in Figure 1.
Clin
Exp
Hyp
erte
ns D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y M
cMas
ter
Uni
vers
ity o
n 11
/28/
14Fo
r pe
rson
al u
se o
nly.
GENETICS OF HYPERTENSION 07 3
Model Far FDH, CHD, & NIDDM
GENES I ENVIRONMENT I 1
Figure1 . A pathophysiologic model is suggested for shared metabolic factors promoting familial dysli idemic hypertension (FDH),,coronary heart disease (CHD , and non-insulin dependent Jabetes mellitus (NIDDM). Other abbreviations used include: FCHL (familial combined hyperli idemla), HBP (high blood pressure), meds (medications), and HDL, LDL, and VLDL Tor hig!, low, and ve low density lipoprotein cholesterol. Single arrows suggest one factor influences the next. Souble arrows suggest both factors influence each other.
WHAT WE STILL DON’T KNOW
It IS dear that genetic factors play an important factor in determining the rlsk of future
hypertenslon. Even speclflc biochemical tests have been shown to be both hlghly genetic and
associated with hypertension. What Is not known Is how predlctlve will these factors be In
predicting future hypertension and how useful they will be as a risk factor battery like
coronary risk factors.
Data consistently suggest both genetic and environmental factors Involving electrolyte
metabdlsm are slgnlflcant determinants of hypertension rlsk. Sodium reduction and calcium
or potasslum supplernentatlon have been associated with a net drop in dlastolic blood pressure
of about 2-3 mmHg (20-21). It Is not yet well established whether or not subsets of
genetlcally susceptlble indlvlduals could show even greater responsiveness to these
lnterventlons while other Individuals In the population are genetically reslstant to even
major changes In dietary electrolyte Intakes.
Clin
Exp
Hyp
erte
ns D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y M
cMas
ter
Uni
vers
ity o
n 11
/28/
14Fo
r pe
rson
al u
se o
nly.
874 WILLIAMS ET AL.
Consistent data associate hypertension with genetically lntiuenced abnormalities in energy
metabdlsm (lipids, obesity, Insulin). lnterventlon studies show a net decrease In
diastolic Mood pressure of 5-10 mmHg in response to weight reductlon or aerobic exercise
(22-23). It Is not known whether or not some lndlvlduals are especially susceptible to these
non-pharmacdoglc interventions and show even more dramatlc improvement In blood pressure
whlle other indivMuais would show iMe or no benefichi change In Mood pressure even in
response to good compliance with these healthy behaviors. it Is also not known how much of
coronary risk associated with hypertension might be attributed to these concomftant
metabolic abnormalities (such as very low HDL-cholesterd) or how much coronary risk from
mild essential hypertenslon would remain even without dysllpklemia present. The main goal
of this overview has been to encourage other Investigators to gain an Interest In asking these
same questions and searchlng for the answers.
REFERENCES
1. Feinleib M: Genetics and famlilai aggregatlon of blood pressure. In: Onesti G, Kllrnt
CR, eds. Hypertension determinants, complications, and Interventlon. New York: Grune
-& Strgtton, 1979: 35.
2. Johnson BC, Epsteln FH, Kjelsberg MO: Distribution and famlllal studies of blood
pressure and serum cholesterol levels in a total communlty-Tecumseh, Mlchlgan. J
Chronic Dls 1965: 18:147.
3. Hayes CG, Tyrder HA, Cassei JC, Hlil C:
County, Georgia. Arch Intern Med 1971; 128:965-75.
Famlly aggregatlon of Mood pressure In Evans
4. Bimn P, Mongeau JG, Bertrand D: Familial aggregatlon of blood pressure In 558 adopted
children. Can Med Assoc J 1976: 15773-4.
5. Felnlelb M, Garrison RJ, Fabskz R, et al: The NHLBl twln study of cardlovascular disease
risk factors: Methodology and summary of results. Am J EpMernld 1977; 106:284-95.
6. Hunt SC, Hasstedt SJ, Kulda H, Stuits EM. Hopklns PN, Williams RR: Genetlc heritability
and common envlronmental components of resting and stressed blood pressures, IipMs,
and body mass index in Utah pedigrees and twins. Am J Epldemld 1989; 129:625-638.
Clin
Exp
Hyp
erte
ns D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y M
cMas
ter
Uni
vers
ity o
n 11
/28/
14Fo
r pe
rson
al u
se o
nly.
GENETICS OF HYPERTENSION a75
7. Berry TD, Hasstedt SJ, Hunt SC, Wu LL, Smith JB, Ash KO, Kukla H, Williams RR: A gene for
high urinary kaiiikrein may protect against hypertension in Utah klndreds. Hypertension
1989; 13336.
8. Hasstedt SJ, Wu LL, Ash KO, Kuida H, Williams RR: Hypertension and sodium-lithium
countertransport in Utah pedigrees: Evklence for major locus Inheritance. Am J Hum
Genet 1988; 43:14-22.
9. .Has@edt SJ, Hunt SC, Wu LL Williams RR: The inheritance of intraerythrocytic sodium
level. Am J Med Genet 1988; 29:193-203.
10. Weinberger MH, Mlller JZ, Fineberg NS, W t FC, Grim CE, Christian JC: Sodlurn
SensitMty and resistance of blood pressure are associated with different haptoglobin
phenotypes. Hypertension 1987; 10:443-6.
11. Wllllams RR: Will gene markers predict hypertension? Hypertension (In press 1989).
12. Hunt SC, McCarron DA, Smith JB, Ash KO, Brlstow MR, Williams RR: The relationship of
plasma Ionized calcium to cardiovascular disease endpoint and family history of
hypertension. Clin & Exp Hypertens 1984; 6:1397-1414.
13. Ufton RP, Hopkins PN, Williams RR, Hdienberg NK, Williams GH, Dluhy RG: Evidence for
heritability of non-modulating essential hypertension. Hypertension 1989; 13:8&4-889.
14. Arnbrosionl E. Costa FV, Montebugnoli 1, et at: IntraIyrnphocytic sodium concentration:
Clin Exp Hypertens A sensitive index to identify young subjects at risk of hypertension.
1981 ; 3575-91.
15. Wnliams RR, Hunt SC, Hopkins PN, Stults BM, Wu U, Hasstedt SJ, Barlow GK. Stephenson SH,
Lalouel JM, Kuida H: Familial dyslipklemlc hypertension: Evidence from 58 Utah families
for a syndrome present in approximately 12% of patients with essential hypertension.
JAMA 1988; 259:35793586.
16. Hunt SC, Wu LL, Hopklns PN, Stub BM, Kulda H, Ramirez ME, Lalouel JM, WHllams RR:
Apolipoproteln, low density llpoproteln subfraction, and insulin associations with
Clin
Exp
Hyp
erte
ns D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y M
cMas
ter
Uni
vers
ity o
n 11
/28/
14Fo
r pe
rson
al u
se o
nly.
WILLIAMS ET AL. 876
familial comblned hyperlipidemla: Study of Utah patients with familial dyslipidemlc
hypertension. Arteriosclerosis 1989; 9:335-344.
17. Wlhms RR, Hunt SC, Hasstedt SJ, Jorde LB, Wu LL, Barlow GK, Ash KO, Stults BM, Kuida
H: The genetics of hypertension: An unsolved p U e with many pieces. In: Human
Qenetics (Vogel F, Sperllng K, Eds). Berlin: Sprlnger-Verlag 1987; pp. 311325.
18. Dluhy RG, Hopkins P, Hollenberg NK, Willlams GH, Willtams RR: Herliable abnormalities
of the renin-angiotensin-aldosterone system in essential hypertenslon. J Cardiovasc
Pharmacd 1988; 12(Suppl3):S149-s154.
19. Wllihms RR, Hunt SC, Hasstedt SJ, Hopkins PN, Wu LL, Berry TD, Stults BM, Barlow GK,
Kuida H: Inherited blmodal traits and susceptibility to hypertension in Utah pedigrees.
in: Salt and Hypertension (Rettlg R, Ganten D, Luff FC, Eds). Heidelberg, FRG:
Sprlnger-Verlag 1989; 139-155.
20. Chalmers JP, Doyle AE, Hopper JL, Howe PRC, Matthews PG, Mathews J, Morgan TO, Moulds RFW,
Nestel P, Scogglns BA, Smith SA. Tonkin A, Whitworth JA, Wing LMH: Fall in blood pressure
wlth modest reductton In dletary salt intake in mild hypertension. Lancet 1989; 1 : s
402.
21. McCarron DA, Morris CD: Blood pressure response to oral calcium in persons with mild to
moderate hypertension. Annals Int Med 1985; 103:825-831.
22. MacMahon SW, Wiicken DEL, Macdonald GJ: The effect of weight reduction on left
ventricular mass: A randomized controlled trkl In young, overwelght hypertensbe
ptlents. New Engl J Med 1986; 314334-9.
23. Duncan JJ. Farr JE, Upton SJ, Hagan RD, Oglesby ME, Blair SN: The effects of aerobk
exercise on plasma catecholamines and Mood pressure In patients with mild essential
hypertenslon. JAMA 1985; 254:2609-2613.
Clin
Exp
Hyp
erte
ns D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y M
cMas
ter
Uni
vers
ity o
n 11
/28/
14Fo
r pe
rson
al u
se o
nly.